Pfizer (NYSE: PFE) announced that it was granted approval from the Canadian Competition Bureau with respect to its pending acquisition ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE